How Do Doctors Tell Wilson Disease Apart from Menkes Disease?

If your child has been found to have a copper metabolism problem, you may have encountered both Wilson disease and Menkes disease mentioned in the same breath. They are related — both disrupt how the body handles copper — but they are profoundly different diseases caused by different genes, affecting different populations, appearing at different ages, and requiring treatments that are essentially opposite in direction. Confusing them, or delaying the distinction, has real consequences for your child.

The Core Difference: Too Much Copper, or Too Little?

Wilson disease and Menkes disease are sometimes called “two sides of the same copper coin.”¹ Here is what that means in practice:

	Wilson Disease	Menkes Disease
Gene affected	ATP7B (chromosome 13)	ATP7A (X chromosome)
Protein function	Copper export from liver cells	Copper absorption from gut / transport into brain
Net effect	Copper accumulates in liver, brain, eyes	Copper cannot reach tissues that need it; brain starved of copper
Who gets it	Males and females equally	Almost exclusively males (X-linked recessive)
Age of onset	Usually 5–35 years; rarely earlier or later	Usually birth to 3 months of age
Treatment direction	Remove excess copper (chelation)	Supply copper in usable form (copper histidine injections)

This table captures the essential point: Wilson disease is about copper toxicity from accumulation; Menkes disease is about copper deficiency from impaired transport. A child receiving the wrong treatment — chelation for what is actually Menkes, or copper supplementation for what is actually Wilson — would be harmed.

How Menkes Disease Presents

Menkes disease is a severe, progressive neurodegenerative disease that typically becomes apparent in infancy, often within the first weeks to months of life. Parents and clinicians notice:

• Unusual, sparse, kinked or twisted hair (the name “kinky hair disease” is an older term for Menkes disease)
• Hypotonia (low muscle tone) and poor feeding
• Progressive neurological deterioration — seizures, loss of developmental milestones
• Skeletal abnormalities visible on X-ray
• Characteristic facial features in some children

Because Menkes disease is X-linked recessive, it affects almost exclusively males. Carrier females (mothers) typically have no symptoms and may have patchy skin or hair pigmentation at most.²

Laboratory findings in Menkes disease are the reverse of what you see in Wilson disease: serum copper and ceruloplasmin are typically very low, reflecting the body’s inability to absorb and distribute copper. This is a critical clue that helps distinguish the two conditions.

How Wilson Disease Presents in Children

Wilson disease rarely becomes symptomatic before the age of 5, and the typical presentation is between 5 and 35 years.³ In children, the presentation is usually liver-dominant first — abnormal liver enzymes found incidentally, hepatitis, or (in a minority) acute liver failure. Neurological symptoms in children with Wilson disease tend to emerge in the teenage years or later.

When a child presents with liver disease and a copper-related abnormality, the age at presentation is one of the most important distinguishing features. An infant with low serum copper and neurological deterioration points toward Menkes; a school-age child with elevated liver enzymes and elevated urine copper points toward Wilson.

The Diagnostic Tests That Distinguish Them

Because the biochemical abnormalities run in opposite directions, the tests that confirm each disease point in different directions too:

Test	Wilson Disease	Menkes Disease
Serum ceruloplasmin	Low (usually)	Very low
Serum copper	Low to normal	Very low
24-hour urine copper	High	Low
Liver copper (biopsy)	Very high	Variable
Kayser-Fleischer rings	Present (especially neurological WD)	Absent
Hair microscopy	Normal	Pili torti (twisted shaft)
Gene test	ATP7B mutations	ATP7A mutations

When the picture is unclear, genetic testing is decisive: both ATP7B and ATP7A can be sequenced to confirm which gene is abnormal.⁴ In Menkes disease, diagnosis can sometimes be made from DNA extracted from a blood sample or, in some cases, from chorionic villus sampling during pregnancy if there is a family history.

Note that some ceruloplasmin results overlap between early Wilson disease and Menkes disease (both can be low), which is why clinical context — age, sex, hair findings, neurological trajectory — is so important alongside the lab values.⁵

Why the Distinction Matters for Treatment

In Wilson disease, the goal is to lower copper levels. This is done with copper-chelating drugs (D-penicillamine or trientine) that pull excess copper out of the body, or with high-dose zinc which blocks copper absorption from food. These treatments are lifelong and highly effective when started early. See medications overview for more on how these work.

In Menkes disease, the goal is the opposite: getting copper into the tissues that cannot receive it. The main treatment is subcutaneous injections of copper histidine, a form of copper that can bypass the ATP7A transport defect and reach the bloodstream. This treatment must be started as early as possible — ideally within the first weeks of life — because brain damage from copper starvation is irreversible.⁶ The window for effective treatment is narrow, which makes early diagnosis critically important in Menkes disease.

If a child with Menkes disease were given copper chelation, it would worsen their already severe copper deficiency. If a child with Wilson disease were given copper supplementation, it would accelerate organ damage from copper toxicity. The stakes of getting the diagnosis right are high.

Rare Overlapping Scenarios

Occasionally, a child’s presentation does not fit cleanly into either category. Some things that can cause confusion:

• Occipital Horn Syndrome (OHS): A milder X-linked condition caused by partial ATP7A dysfunction, presenting later than classic Menkes with connective tissue and skeletal problems rather than severe neurodegeneration.
• Very mild or partial Menkes: A small subset of ATP7A mutations cause milder phenotypes that may not present in infancy.
• Wilson disease in a very young child: True Wilson disease below age 5 is rare but documented. If a young child has liver failure and elevated liver copper, Wilson disease can be confirmed by liver biopsy and genetic testing even at age 3 or 4.

In any of these ambiguous situations, referral to a specialist in copper metabolism disorders at an academic centre is warranted. This is a rare enough clinical scenario that most general paediatricians will have limited experience, and the consequences of error are serious.⁴

Talking to Your Child’s Medical Team

If your child has been diagnosed with a copper metabolism disorder and you are uncertain which condition you are dealing with, these questions will help clarify:

• “Is this condition due to excess copper or insufficient copper reaching the tissues?”
• “Which gene has been tested — ATP7B or ATP7A, or both?”
• “Is the age of onset and sex of my child consistent with the diagnosis?”
• “Has a copper metabolism specialist — pediatric hepatologist or metabolic disease physician — reviewed this case?”

For Wilson disease specifically, see how is it diagnosed for a fuller explanation of the diagnostic pathway once Wilson disease is confirmed as the working diagnosis.

This article is patient education, not medical advice. Differentiating Wilson disease from Menkes disease and other copper metabolism disorders requires specialist evaluation, including laboratory testing, genetic analysis, and clinical judgment. Do not attempt to adjust treatment based on general information — contact your child’s specialist.

References